HUREL Micro Livers

Metabolically and phenotypically stable liver models

Visikol recently acquired the HUREL portfolio of products and services which include over ten different species of primary hepatocyte liver models. 

The HUREL platform provides researchers with a long-term culture solution for assessing drug metabolism, low clearance compounds, drug induced liver injury, HBV and various other applications.